Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Collect Patients, Medical, and Biological Data From Patients Being Treated for Metastatic Colorectal Cancer With a Specific Genetic Mutation: BRAFV600E

NCT05639413 is registered in ClinicalTrials.gov with UNICANCER as lead sponsor.

NCT NCT05639413
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05639413 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Collect Patients, Medical, and Biological Data From Patients Being Treated for Metastatic Colorectal Cancer With a Specific Genetic Mutation: BRAFV600E
Lead sponsor
UNICANCER
Phase
Not applicable
Overall status
Recruiting
Start date
July 24, 2023
Completion date
July 31, 2028
Enrollment
400 (estimated)
Sites
45

Conditions

As the registry lists them; a condition with its own page is linked.

braf v600e mutation positive, metastatic colorectal cancer